State of New Jersey Common Pension Fund D’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,602
Closed -$522K 1740
2026
Q1
$522K Buy
15,602
+184
+1% +$7.21K ﹤0.01% 1455
2025
Q4
$714K Sell
15,418
-15,056
-49% -$826K ﹤0.01% 1417
2025
Q3
$2.06M Buy
+30,474
New +$2.26M 0.01% 1265

State of New Jersey Common Pension Fund D's SLNO Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 15,602 shares — an estimated $522K sold.

State of New Jersey Common Pension Fund D first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $2.06M in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • State of New Jersey Common Pension Fund D reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 15,602 Soleno Therapeutics shares in Q2 2026, an estimated $522K.
  • State of New Jersey Common Pension Fund D first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
  • State of New Jersey Common Pension Fund D's Soleno Therapeutics position peaked at $2.06M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.